Skip to main content

Chesterfield pharma company Indivior aims to list on Nasdaq in June

The opioid addiction treatment company recently closed on a strategic acquisition.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.